Sector Focus


Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.


GenStar Therapeutics Corporation (now VIA Pharmaceuticals)

GenStar Therapeutics was a biopharmaceutical company developing innovative gene therapy products, for the treatment of serious medical disorders. The Company's research and development efforts, utilizing advanced gene delivery technologies, are focused on hemophilia, cancer, and HIV/AIDS. The company merged and the new company was later acquired by VIA Pharmaceuticals.

Search Projects

  • Vice President, Clinical Research